Dangerous viruses pose a global, persistent and unavoidable threat to humanity.

What if we could predict which variants of a virus are of greatest concern and design medicines to protect against them, a priori?

Many of the world’s most threatening viruses are continually evolving, outwitting our immune systems, outpacing efforts to develop new effective medicines and causing untold human suffering.

Our pioneering approach centers on a unique technology platform which allows us to survey the entire landscape of existing and potential viral variants to design new vaccines and antibody drugs against the most threatening variants.

Founded by Flagship Pioneering, Apriori is a leading health security company with a mission to provide humanity with variant-proof protection against rapidly-evolving viruses.


Balint Antal, PhD, Senior Scientist

Balint Antal, PhD

Senior Scientist

Sukhmani Bedi, PhD, Scientist II

Sukhmani Bedi, PhD

Scientist II

Charlens Beneche, Research Associate II

Charlens Beneche

Research Associate II

Yvonne Chan, PhD, Senior Scientist

Yvonne Chan, PhD

Senior Scientist

Julia Chartove, PhD, Scientist II

Julia Chartove, PhD

Scientist II

David Chiovitti, Scientist II

David Chiovitti

Scientist II

Gus Dunn, PhD, Associate Director

Gus Dunn, PhD

Associate Director

Jack Holland, PhD, Scientist

Jack Holland, PhD


Anna Honko, PhD, Director of Preclinical Biology

Anna Honko, PhD

Director of Preclinical Biology

Christine Isabella, PhD, Scientist II

Christine Isabella, PhD

Scientist II

Patrick Jones, PhD, MBA, Head of R&D Strategy

Patrick Jones, PhD, MBA

Head of R&D Strategy

Dina Magner, Senior Research Associate II

Dina Magner

Senior Research Associate II

Crystal Mendoza-Lopez, PhD, Scientist

Crystal Mendoza-Lopez, PhD


Diego Mourao, PhD, Senior Scientist II

Diego Mourao, PhD

Senior Scientist II

Al Swiston, PhD, Head of Data Science

Al Swiston, PhD

Head of Data Science

Caroline Wilkinson, Senior Engineer

Caroline Wilkinson

Senior Engineer

Jeremy Yethon, PhD, Head of Biology

Jeremy Yethon, PhD

Head of Biology


Jesse Bloom, PhD

Scientific Advisor

Professor, Fred Hutch

HHMI Investigator

Arup Chakraborty, PhD

Scientific Advisor and Academic Partner, Flagship Pioneering

Institute Professor at MIT

Founding Steering Committee Member, Ragon Institute

Tom DiLenge

Senior Partner, Flagship Pioneering

Global Public Policy, Regulatory & Governmental Strategy

Stephen Hahn, MD

CEO-Partner, Flagship Pioneering and CEO, Harbinger Health

U.S. FDA Commissioner 2019-21

Michel C. Nussenzweig, MD, PhD

Scientific Advisor

Zanvil A. Cohn and Ralph M. Steinman Professor and Senior Physician, The Rockefeller University

HHMI Investigator

Wellington Sun, MD

Former Head of Vaccine Strategy, Moderna

Former Director, FDA Division of Vaccines

Andrew Weber

Senior Advisor

Former Assistant U.S. Secretary of Defense